Newborn Screening at Mayo Clinic Laboratories

Newborn screening is intended to detect serious health conditions in babies for which early intervention can greatly improve healthy development and positive outcomes.

Own your lab, own your future - Insights

The laboratory is the cornerstone for health systems that offer complex care. Learn how lab ownership is a key driver of patient care excellence and health system growth.

Testing Archives - Page 25 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

New tests launched in November - Insights

In November 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Novel panel identifies toxins linked to asthma and GI diseases - Insights

Melissa Snyder, Ph.D., explains how Mayo Clinic Laboratories' EDN panel improves the evaluation of certain patients with asthma and autoimmune digestive disorders. EDN is the first laboratory test that provides a marker of...

New Tests Launched Archives - Page 5 of 6 - Insights

Skip to Content MayoACCESS MayoLINK...

Chain of Custody Testing - Insights

Loralie Langman, Ph.D., explains the difference between chain of custody and clinical toxicology testing. Chain of custody is a process used for toxicology testing when the results might have legal implications for the individual tested....

Updated testing algorithms for plasma cell proliferative disorders [Test in Focus] - Insights

Xinjie Xu, Ph.D., co-director of Mayo's Genetics and Genomics Laboratory, explains Mayo Clinic Laboratories' updated approach to testing for risk stratification of patients newly diagnosed with plasma cell proliferative disorders, such as...

Liquid biopsy cancer testing - Insights

Learn how the pioneering approach used in liquid biopsy testing available through Mayo Clinic Laboratories enables individualized insights that drive personalized care.

New Tests Launched Archives - Page 2 of 6 - Insights

Skip to Content MayoACCESS MayoLINK...